TFB2M Antibodies

Santa Cruz Biotechnology delivers a wide array of TFB2M monoclonal antibodies for research focused on understanding mitochondrial transcription machinery. TFB2M monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFB2M, or Transcription Factor B2, functions as a key component in mitochondrial transcription machinery, significantly influencing mitochondrial gene expression. TFB2M plays an essential role in maintaining proper mitochondrial function, which directly impacts energy production and cellular metabolism. Research involving TFB2M has revealed its importance in understanding various mitochondrial disorders and their connection to human diseases. Investigating TFB2M expression patterns and interactions provides valuable insights into cellular energy metabolism and mitochondrial DNA maintenance. Advanced research techniques utilizing TFB2M monoclonal antibodies enable detailed examination of mitochondrial transcription processes. Understanding TFB2M's regulatory mechanisms contributes to knowledge about mitochondrial dysfunction in various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of mitochondrial biology and its implications in human health.